hotspot -WSS

hotspot

author：fashion 2025-09-28 13:23:53 - browse：333

Zepbound, a injectable drug on a gradient background of dark purple and green — biotech coverage from STAT — Illustration: STAT; Source: Eli Lilly/AP

A California biotech developing a combination therapy with the obesity drug Zepbound has raised a $170 million Series D round.

The company, BioAge, raised money from more than a dozen investors. Sofinnova Investments led the round, which also included Eli Lilly and Amgen’s venture arms and previous investor Andreessen Horowitz.

BioAge’s primary focus is in developing medications that boost a person’s healthspan, or the number of healthy years a person lives. The company has drugs in development for neuroinflammation and brain aging. But the majority of the Series D proceeds will be used to develop the company’s lead drug candidate azelaprag, which is being tested in combination with Zepbound. That drug program is what grabbed Sofinnova’s attention, according to managing partner Jim Healy, who recently became chairman of BioAge’s board.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Medicare to cover more brain scans for Alzheimer’s patients

WSS

Group opposing PBM reform sets lobbying record

Medicare has a new plan to address drug shortages

Medicare has a new plan to address drug shortages

How dance can help health care workers heal from trauma

At Orexo, a ‘turning point’ for everything but digital health

Group opposing PBM reform sets lobbying record

entertainment

hotspot

leisure time

Jerome Adams on the need for new antivirals for Covid

Listen: Wegovy in the brain & pivotal Alzheimer's data

Peter Hotez and the public health issue of online harassment

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

As demand for Covid shots wanes, Moderna seeks its next success

Researchers separate signal from noise in heart wearable data

Trump demands the U.S. pay no more for drugs than other countries … again

WHO calls for emergency meeting on new China virus, as cases spread

Cancer drug shortages should be causing more outrage

Seattle police shoot person suspected in downtown stabbing

explore

Why the Crimean Bridge is key to Russia's war in Ukraine

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Group opposing PBM reform sets lobbying record

How Medicaid coverage policies for immigrants impact new moms

Why the Crimean Bridge is key to Russia's war in Ukraine

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

hotspot

hotspot

focus

explore